A detailed history of Thrivent Financial For Lutherans transactions in Organon & Co. stock. As of the latest transaction made, Thrivent Financial For Lutherans holds 202,190 shares of OGN stock, worth $3.15 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
202,190
Previous 213,490 5.29%
Holding current value
$3.15 Million
Previous $4.42 Million 12.47%
% of portfolio
0.01%
Previous 0.01%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$18.65 - $23.03 $210,744 - $260,239
-11,300 Reduced 5.29%
202,190 $3.87 Million
Q2 2024

Aug 13, 2024

SELL
$17.45 - $21.96 $891,450 - $1.12 Million
-51,086 Reduced 19.31%
213,490 $4.42 Million
Q1 2024

May 14, 2024

SELL
$13.78 - $18.8 $417,961 - $570,222
-30,331 Reduced 10.28%
264,576 $4.97 Million
Q4 2023

Feb 14, 2024

BUY
$10.95 - $17.32 $3.11 Million - $4.92 Million
284,164 Added 2645.11%
294,907 $4.25 Million
Q3 2023

Nov 14, 2023

SELL
$16.59 - $23.77 $1,907 - $2,733
-115 Reduced 1.06%
10,743 $186,000
Q2 2023

Aug 14, 2023

SELL
$19.27 - $24.63 $1,175 - $1,502
-61 Reduced 0.56%
10,858 $226,000
Q1 2023

May 17, 2023

BUY
$21.42 - $32.08 $535 - $802
25 Added 0.23%
10,919 $257,000
Q4 2022

Feb 08, 2023

BUY
$23.31 - $28.61 $1,072 - $1,316
46 Added 0.42%
10,894 $304,000
Q3 2022

Nov 14, 2022

BUY
$23.4 - $34.25 $1,988 - $2,911
85 Added 0.79%
10,848 $254,000
Q2 2022

Aug 16, 2022

BUY
$31.66 - $38.9 $1,266 - $1,556
40 Added 0.37%
10,763 $363,000
Q1 2022

May 13, 2022

SELL
$30.45 - $39.36 $2,375 - $3,070
-78 Reduced 0.72%
10,723 $375,000
Q4 2021

Feb 16, 2022

SELL
$28.67 - $37.13 $2,121 - $2,747
-74 Reduced 0.68%
10,801 $329,000
Q3 2021

Nov 15, 2021

SELL
$28.63 - $35.64 $588,031 - $732,009
-20,539 Reduced 65.38%
10,875 $357,000
Q2 2021

Aug 19, 2021

BUY
$28.45 - $38.0 $893,728 - $1.19 Million
31,414 New
31,414 $951,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.96B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Thrivent Financial For Lutherans Portfolio

Follow Thrivent Financial For Lutherans and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Thrivent Financial For Lutherans, based on Form 13F filings with the SEC.

News

Stay updated on Thrivent Financial For Lutherans with notifications on news.